Evidence map›Paper›PMID 28634120›Full record

ArticleJournal of proteomics2017

Highly reproducible improved label-free quantitative analysis of cellular phosphoproteome by optimization of LC-MS/MS gradient and analytical column construction.

Nagib Ahsan, Judson Belmont, Zhuo Chen, James G Clifton, Arthur R Salomon

Abstract read
In one paragraph

Article in Journal of proteomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Hyperoxia impairs intraflagellar transport and causes dysregulated metabolism with resultant decreased cilia length.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nagib AhsanDivision of Biology and Medicine, Brown University, Providence, RI 02903, USA; Center for Cancer Research Development, Proteomics Core Facility, Rhode Island Hospital, Providence, RI 02903, USA.
Judson BelmontDepartment of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA.
Zhuo ChenDepartment of Chemistry, Brown University, Providence, RI 02912, USA.
James G CliftonDepartment of Molecular Pharmacology, Physiology and Biotechnology, Brown, University, Providence, RI 02912, USA.
Arthur R SalomonCenter for Cancer Research Development, Proteomics Core Facility, Rhode Island Hospital, Providence, RI 02903, USA; Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA; Department of Chemistry, Brown University, Providence, RI 02912, USA. Electronic address: as@brown.edu.
Brown University · USCenter for Cancer Research · USRhode Island Hospital · US

Funding

Understand the metabolic fitness of naïve T cellsP01AI091580 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JEROEN ROOSE · 2011 to 2026
$31.1M
TRAINING IN MOLECULAR &CELL BIOLOGY &BIOCHEMISTRYT32GM007601 · NIGMS · BROWN UNIVERSITY · PI MOWRY, KIMBERLY L. · 1985 to 2019
$6.4M
COBRE Center for Cancer Research DevelopmentP30GM110759 · NIGMS · RHODE ISLAND HOSPITAL · PI RAMRATNAM, BHARAT · 2015 to 2019
$6.3M
Phosphoproteomic Analysis of T Cell Activation PathwaysR01AI083636 · NIAID · BROWN UNIVERSITY · PI SALOMON, ARTHUR ROBERT · 2010 to 2021
$4.0M
Acquisition of an Orbitrap XL ETD Mass Spectrometer through Upgrading an LTQS10RR027027 · NCRR · BROWN UNIVERSITY · PI HAWROT, EDWARD · 2010 to 2010
$500k
NCRR NIH HHS S10 RR027027NIAID NIH HHS P01 AI091580NIAID NIH HHS R01 AI083636NIGMS NIH HHS P30 GM110759NIGMS NIH HHS T32 GM007601
6 · The paper itself

Abstract

Expanding the sequencing depth of the peptides with a statistically significant quantitative change derived from a biological stimulation is critical. Here we demonstrate that optimization of LC gradient and analytical column construction can reveal over 30,000 unique peptides and 23,000 phosphopeptides at high confidence. The quantitative reproducibility of different analytical workflows was evaluated by comparing the phosphoproteome of CD3/4 stimulated and unstimulated T-cells as a model system. A fritless, 50cm-long column packed with 1.9μm particles operated with a standard pressure HPLC significantly improved the sequencing depth 51% and decreased the selected ion chromatogram peak spreading. Most importantly, under the optimal workflow we observed an improvement of over 300% in detection of significantly changed phosphopeptides in the stimulated cells compared with the other workflows. The discovery power of the optimized column configuration was illustrated by identification of significantly altered phosphopeptides harboring novel sites from proteins previously established as important in T cell signaling including A-Raf, B-Raf, c-Myc, CARMA1, Fyn, ITK, LAT, NFAT1/2/3, PKCα, PLCγ1/2, RAF1, and SOS1. Taken together, our results reveal the analytical power of optimized chromatography using sub 2μm particles for the analysis of the T cell phosphoproteome to reveal a vast landscape of significantly altered phosphorylation changes in response to T cell receptor stimulation.

Indexed as

AnimalsChromatography, LiquidEquipment DesignHumansLymphocyte ActivationPhosphopeptidesPhosphoproteinsPhosphorylationProteomeProteomicsReproducibility of ResultsSignal TransductionTandem Mass SpectrometryT-LymphocytesWorkflowPhosphopeptidesPhosphoproteinsProteomeLabel free quantificationLC-MS/MSQuantitative phosphoproteomicsSub 2μm C18 particlesT cell signaling

Identifiers

PMID28634120
PMCPMC5542054
OpenAlexW2707568461

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.